Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.
BACKGROUND: Alemtuzumab (MabCampath or Campath; Genzyme, Cambridge, MA) is a CD52-specific monoclonal antibody that causes profound and sustained lymphocyte depletion. Its use as an induction therapy in organ transplantation is increasing. Since our last systematic review in 2006, where we identifi...
Главные авторы: | Morgan, R, O'Callaghan, J, Knight, SR, Morris, P |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2012
|
Схожие документы
-
Systematic reviews of alemtuzumab in renal transplantation.
по: O'Callaghan, J, и др.
Опубликовано: (2013) -
Systematic reviews of alemtuzumab in renal transplantation
по: O'Callaghan, J, и др.
Опубликовано: (2013) -
Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes.
по: O'Callaghan, J, и др.
Опубликовано: (2013) -
Preservation solutions for static cold storage of kidney allografts: A systematic review and meta-analysis
по: O'Callaghan, J, и др.
Опубликовано: (2012) -
Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis.
по: O'Callaghan, J, и др.
Опубликовано: (2012)